Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

This Baby Biotech Firm Is Making a $400 Million Market Move

Galapagos NV (Nasdaq ADR: GLPG) is at it again.

The Mechelen, Belgium-based Galapagos recently announced plans for a global offering of common stock.

But there's a twist...

As part of the offering, Galapagos has asked the U.S. Securities and Exchange Commission (SEC) for permission to offer shares here in the U.S. market in the form of "American Depositary Shares" (ADS) that will supplant its current over-the-counter (OTC)/American Depository Receipt (ADR) shares.

This isn't the first time we've seen this sort of ADS scheme from our "Baby Biotech" play.

  1. Flx Temp | April 24, 2017

    Speaking of Boitechs, what is your take on Trovagene at this time?

    • MULLEN93904 | April 26, 2017

      I got tired of looking at it gradually drop and dropped it.

      • Daniel Williams | May 10, 2017

        Still holding Trov and hoping. But it looks discouraging now.

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK